HP Cell Vitaran I II (1x2 ml)

HP Cell Vitaran

Aesthetic / Dermatology Injectable

Polynucleotide Skin Booster

CE Marked (as indicated by some distributors for Vitaran II)

CE Marked (as indicated by some distributors for Vitaran II)

Polynucleotide Skin Booster

Description

HP Cell Vitaran I II (1x2 ml) is a polynucleotide-based tissue-stimulating injectable formulated for intensive skin moisturization, revitalization, and biostimulation. It contains purified polynucleotides (PN) at 20 mg/ml and is provided in a 2 ml pre-filled sterile syringe (with 33G × 4 mm needle), intended for professional aesthetic use on the face or other suitable areas.

Bnefits

Deep skin hydration and moisturization
Improved skin firmness and elasticity
Reduction in appearance of fine lines and wrinkles
Stimulation of skin regeneration and tissue repair
Enhanced skin tone and colour, revitalizing dull or dehydrated skin
Suitable for dry, dehydrated or damaged skin (e.g. smokers’ skin)
Long-lasting effects — results may last up to 7-9 months

Indications

Skin hydration and revitalization
Improvement of skin laxity and loss of firmness
Treatment of fine lines and signs of ageing
Skin revitalization for dry, dehydrated, or environmentally stressed skin
General skin-rejuvenation protocols in aesthetic practice

Composition

Polynucleotide sodium (PN) 20 mg/ml (2%)
Sterile buffer/solvent (exact composition not publicly disclosed)

Formulation

Sterile injectable gel solution containing polynucleotides
Presented in 1 × 2 ml pre-filled syringe
Includes a 33 G × 4 mm sterile needle for administration

Packaging

Single-use sterile 2 ml pre-filled syringe with attached needle
Individually sealed and intended for single patient use (professional use only)

Usage

Product should be administered by a qualified medical/aesthetic professional trained in polynucleotide injectable protocols.
Inject into skin at appropriate depth according to clinical protocol (needle gauge 33 G × 4 mm provided).
Use aseptic technique and adhere to local clinical and hygiene guidelines.
Treatment may be repeated after 20–30 days if required (as indicated by certain distributors).

Contraindications

Known allergy or hypersensitivity to polynucleotides or fish-derived DNA (salmon / trout).
Active skin infection, inflammation, or compromised skin integrity at the injection site.
Pregnancy or breastfeeding (if contraindicated by treating physician or local regulations).
Patients under 18 years of age, according to some sources.

Adverse Effects

As with any injectable: risk of injection site reactions such as redness, swelling, bruising, or discomfort.
Potential for allergic reaction especially in individuals with fish-derived DNA sensitivity.
Risk of infection if aseptic technique is not followed.